Here's how LINK.SPRINGER.COM makes money* and how much!

*Please read our disclaimer before using our estimates.
Loading...

LINK . SPRINGER . COM {}

  1. Analyzed Page
  2. Matching Content Categories
  3. CMS
  4. Monthly Traffic Estimate
  5. How Does Link.springer.com Make Money
  6. Keywords
  7. Topics
  8. Questions
  9. Schema
  10. External Links
  11. Analytics And Tracking
  12. Libraries
  13. CDN Services

We are analyzing https://link.springer.com/article/10.1186/s40425-018-0460-5.

Title:
Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance | Journal for ImmunoTherapy of Cancer
Description:
Chimeric Antigen Receptor (CAR) T cell therapies – adoptive T cell therapies that have been genetically engineered for a new antigen-specificity - have displayed significant success in treating patients with hematologic malignancies, leading to three recent US Food and Drug Administration approvals. Based on the promise generated from these successes, the field is rapidly evolving to include new disease indications and CAR designs, while simultaneously reviewing and optimizing toxicity and management protocols. As such, this review provides expert perspective on the significance and clinical considerations of CAR T cell therapies in order to provide timely information to clinicians about this revolutionary new therapeutic class.
Website Age:
28 years and 1 months (reg. 1997-05-29).

Matching Content Categories {📚}

  • Insurance
  • Science
  • Education

Content Management System {📝}

What CMS is link.springer.com built with?

Custom-built

No common CMS systems were detected on Link.springer.com, and no known web development framework was identified.

Traffic Estimate {📈}

What is the average monthly size of link.springer.com audience?

🌠 Phenomenal Traffic: 5M - 10M visitors per month


Based on our best estimate, this website will receive around 5,000,016 visitors per month in the current month.

check SE Ranking
check Ahrefs
check Similarweb
check Ubersuggest
check Semrush

How Does Link.springer.com Make Money? {💸}

We can't see how the site brings in money.

Websites don't always need to be profitable; some serve as platforms for education or personal expression. Websites can serve multiple purposes. And this might be one of them. Link.springer.com might be cashing in, but we can't detect the method they're using.

Keywords {🔍}

car, cells, cell, pubmed, patients, article, google, scholar, cas, therapy, antigen, therapies, central, clinical, treatment, crs, patient, chimeric, receptor, cancer, grade, multiple, fda, efficacy, anticd, leukemia, trial, response, data, phase, immunotherapy, received, disease, lymphoma, med, toxicities, tisagenlecleucel, studies, myeloma, clin, including, infusion, acute, observed, domain, cres, research, malignancies, tumor, blood,

Topics {✒️}

anti-cd19 chimeric-antigen-receptor-transduced anti-cd19/cd20 bi-specific car anti-bcma antigen-recognition domain chimeric antigen receptor-modified crispr/cas9-driven car localization adoptive t-cell therapy extracellular antigen-binding domain prior stem-cell transplant article download pdf b-cell maturation antigen antigen-specific targeted therapies car t-related encephalopathy b-cell lymphoblastic leukemia nonsteroidal anti-inflammatory drugs liso-cel pre-infusion products car t-cell therapy car t-related crs chimeric antigen receptor refractory b-cell lymphomas require pd-l1 positivity car-encoding viral vectors indolent b-cell malignancies natural anti-tumor recognition combining anti-cd19 car stem cell transplant cd19-targeted car immunotherapy subsequent cyclophosphamide/fludaribine lymphodepletion cell antigen receptor cell maturation antigen t-cell therapy acute myeloid leukemia acute lymphoblastic leukaemia large-volume leukapheresis procedure bb2121 anti-bcma car chimeric antigen receptors castration-resistant prostate cancer brudno jn blood-brain barrier disruption cell-mediated tumor eradication relapsed/refractory multiple myeloma refractory/relapsed multiple myeloma hypotension requiring high-dose acute lymphoid leukemia anti-cd19 car infusion potent antitumor effects cell therapy access adoptive cell therapy bi-specific car acute myeloblastic leukemia alternative costimulatory domains

Questions {❓}

  • Acute myeloid leukemia chimeric antigen receptor T-cell immunotherapy: how far up the road have we traveled?

Schema {🗺️}

WebPage:
      mainEntity:
         headline:Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
         description:Chimeric Antigen Receptor (CAR) T cell therapies – adoptive T cell therapies that have been genetically engineered for a new antigen-specificity - have displayed significant success in treating patients with hematologic malignancies, leading to three recent US Food and Drug Administration approvals. Based on the promise generated from these successes, the field is rapidly evolving to include new disease indications and CAR designs, while simultaneously reviewing and optimizing toxicity and management protocols. As such, this review provides expert perspective on the significance and clinical considerations of CAR T cell therapies in order to provide timely information to clinicians about this revolutionary new therapeutic class.
         datePublished:2018-12-04T00:00:00Z
         dateModified:2018-12-04T00:00:00Z
         pageStart:1
         pageEnd:12
         license:http://creativecommons.org/publicdomain/zero/1.0/
         sameAs:https://doi.org/10.1186/s40425-018-0460-5
         keywords:
            Chimeric antigen receptor
            Tisagenlecleucel
            Axicabtagene ciloleucel
            Leukemia
            Lymphoma
            Oncology
            Immunology
         image:
            https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-018-0460-5/MediaObjects/40425_2018_460_Fig1_HTML.png
         isPartOf:
            name:Journal for ImmunoTherapy of Cancer
            issn:
               2051-1426
            volumeNumber:6
            type:
               Periodical
               PublicationVolume
         publisher:
            name:BioMed Central
            logo:
               url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
               type:ImageObject
            type:Organization
         author:
               name:Michael M. Boyiadzis
               affiliation:
                     name:University of Pittsburgh
                     address:
                        name:University of Pittsburgh, Pittsburgh, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Madhav V. Dhodapkar
               affiliation:
                     name:Winship Cancer Institute, Emory University
                     address:
                        name:Winship Cancer Institute, Emory University, Atlanta, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Renier J. Brentjens
               affiliation:
                     name:Memorial Sloan Kettering Cancer Center
                     address:
                        name:Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:James N. Kochenderfer
               affiliation:
                     name:Experimental Transplantation and Immunology Branch, National Cancer Institute
                     address:
                        name:Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Sattva S. Neelapu
               affiliation:
                     name:The University of Texas MD Anderson Cancer Center
                     address:
                        name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Marcela V. Maus
               affiliation:
                     name:Massachusetts General Hospital/Harvard Medical School
                     address:
                        name:Massachusetts General Hospital/Harvard Medical School, Boston, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David L. Porter
               affiliation:
                     name:Perelman School of Medicine at the University of Pennsylvania
                     address:
                        name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:David G. Maloney
               affiliation:
                     name:Fred Hutchinson Cancer Research Center
                     address:
                        name:Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Stephan A. Grupp
               affiliation:
                     name:Perelman School of Medicine at the University of Pennsylvania
                     address:
                        name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
                     name:Cancer Immunotherapy Program, Children’s Hospital of Philadelphia
                     address:
                        name:Division of Oncology, Cancer Immunotherapy Program, Children’s Hospital of Philadelphia, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Crystal L. Mackall
               affiliation:
                     name:Stanford University
                     address:
                        name:Cancer Immunology and Immunotherapy Program, Stanford University, Stanford, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Carl H. June
               affiliation:
                     name:Perelman School of Medicine at the University of Pennsylvania
                     address:
                        name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
                        type:PostalAddress
                     type:Organization
               type:Person
               name:Michael R. Bishop
               url:http://orcid.org/0000-0001-6708-1536
               affiliation:
                     name:University of Chicago
                     address:
                        name:Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
                     name:The University of Chicago
                     address:
                        name:The University of Chicago, Chicago, USA
                        type:PostalAddress
                     type:Organization
               email:[email protected]
               type:Person
         isAccessibleForFree:1
         type:ScholarlyArticle
      context:https://schema.org
ScholarlyArticle:
      headline:Chimeric antigen receptor (CAR) T therapies for the treatment of hematologic malignancies: clinical perspective and significance
      description:Chimeric Antigen Receptor (CAR) T cell therapies – adoptive T cell therapies that have been genetically engineered for a new antigen-specificity - have displayed significant success in treating patients with hematologic malignancies, leading to three recent US Food and Drug Administration approvals. Based on the promise generated from these successes, the field is rapidly evolving to include new disease indications and CAR designs, while simultaneously reviewing and optimizing toxicity and management protocols. As such, this review provides expert perspective on the significance and clinical considerations of CAR T cell therapies in order to provide timely information to clinicians about this revolutionary new therapeutic class.
      datePublished:2018-12-04T00:00:00Z
      dateModified:2018-12-04T00:00:00Z
      pageStart:1
      pageEnd:12
      license:http://creativecommons.org/publicdomain/zero/1.0/
      sameAs:https://doi.org/10.1186/s40425-018-0460-5
      keywords:
         Chimeric antigen receptor
         Tisagenlecleucel
         Axicabtagene ciloleucel
         Leukemia
         Lymphoma
         Oncology
         Immunology
      image:
         https://media.springernature.com/lw1200/springer-static/image/art%3A10.1186%2Fs40425-018-0460-5/MediaObjects/40425_2018_460_Fig1_HTML.png
      isPartOf:
         name:Journal for ImmunoTherapy of Cancer
         issn:
            2051-1426
         volumeNumber:6
         type:
            Periodical
            PublicationVolume
      publisher:
         name:BioMed Central
         logo:
            url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
            type:ImageObject
         type:Organization
      author:
            name:Michael M. Boyiadzis
            affiliation:
                  name:University of Pittsburgh
                  address:
                     name:University of Pittsburgh, Pittsburgh, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Madhav V. Dhodapkar
            affiliation:
                  name:Winship Cancer Institute, Emory University
                  address:
                     name:Winship Cancer Institute, Emory University, Atlanta, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Renier J. Brentjens
            affiliation:
                  name:Memorial Sloan Kettering Cancer Center
                  address:
                     name:Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:James N. Kochenderfer
            affiliation:
                  name:Experimental Transplantation and Immunology Branch, National Cancer Institute
                  address:
                     name:Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Sattva S. Neelapu
            affiliation:
                  name:The University of Texas MD Anderson Cancer Center
                  address:
                     name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Marcela V. Maus
            affiliation:
                  name:Massachusetts General Hospital/Harvard Medical School
                  address:
                     name:Massachusetts General Hospital/Harvard Medical School, Boston, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David L. Porter
            affiliation:
                  name:Perelman School of Medicine at the University of Pennsylvania
                  address:
                     name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:David G. Maloney
            affiliation:
                  name:Fred Hutchinson Cancer Research Center
                  address:
                     name:Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Stephan A. Grupp
            affiliation:
                  name:Perelman School of Medicine at the University of Pennsylvania
                  address:
                     name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
                  name:Cancer Immunotherapy Program, Children’s Hospital of Philadelphia
                  address:
                     name:Division of Oncology, Cancer Immunotherapy Program, Children’s Hospital of Philadelphia, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Crystal L. Mackall
            affiliation:
                  name:Stanford University
                  address:
                     name:Cancer Immunology and Immunotherapy Program, Stanford University, Stanford, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Carl H. June
            affiliation:
                  name:Perelman School of Medicine at the University of Pennsylvania
                  address:
                     name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
                     type:PostalAddress
                  type:Organization
            type:Person
            name:Michael R. Bishop
            url:http://orcid.org/0000-0001-6708-1536
            affiliation:
                  name:University of Chicago
                  address:
                     name:Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
                  name:The University of Chicago
                  address:
                     name:The University of Chicago, Chicago, USA
                     type:PostalAddress
                  type:Organization
            email:[email protected]
            type:Person
      isAccessibleForFree:1
["Periodical","PublicationVolume"]:
      name:Journal for ImmunoTherapy of Cancer
      issn:
         2051-1426
      volumeNumber:6
Organization:
      name:BioMed Central
      logo:
         url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
         type:ImageObject
      name:University of Pittsburgh
      address:
         name:University of Pittsburgh, Pittsburgh, USA
         type:PostalAddress
      name:Winship Cancer Institute, Emory University
      address:
         name:Winship Cancer Institute, Emory University, Atlanta, USA
         type:PostalAddress
      name:Memorial Sloan Kettering Cancer Center
      address:
         name:Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
         type:PostalAddress
      name:Experimental Transplantation and Immunology Branch, National Cancer Institute
      address:
         name:Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, USA
         type:PostalAddress
      name:The University of Texas MD Anderson Cancer Center
      address:
         name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
         type:PostalAddress
      name:Massachusetts General Hospital/Harvard Medical School
      address:
         name:Massachusetts General Hospital/Harvard Medical School, Boston, USA
         type:PostalAddress
      name:Perelman School of Medicine at the University of Pennsylvania
      address:
         name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
         type:PostalAddress
      name:Fred Hutchinson Cancer Research Center
      address:
         name:Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA
         type:PostalAddress
      name:Perelman School of Medicine at the University of Pennsylvania
      address:
         name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
         type:PostalAddress
      name:Cancer Immunotherapy Program, Children’s Hospital of Philadelphia
      address:
         name:Division of Oncology, Cancer Immunotherapy Program, Children’s Hospital of Philadelphia, Philadelphia, USA
         type:PostalAddress
      name:Stanford University
      address:
         name:Cancer Immunology and Immunotherapy Program, Stanford University, Stanford, USA
         type:PostalAddress
      name:Perelman School of Medicine at the University of Pennsylvania
      address:
         name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
         type:PostalAddress
      name:University of Chicago
      address:
         name:Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, USA
         type:PostalAddress
      name:The University of Chicago
      address:
         name:The University of Chicago, Chicago, USA
         type:PostalAddress
ImageObject:
      url:https://www.springernature.com/app-sn/public/images/logo-springernature.png
Person:
      name:Michael M. Boyiadzis
      affiliation:
            name:University of Pittsburgh
            address:
               name:University of Pittsburgh, Pittsburgh, USA
               type:PostalAddress
            type:Organization
      name:Madhav V. Dhodapkar
      affiliation:
            name:Winship Cancer Institute, Emory University
            address:
               name:Winship Cancer Institute, Emory University, Atlanta, USA
               type:PostalAddress
            type:Organization
      name:Renier J. Brentjens
      affiliation:
            name:Memorial Sloan Kettering Cancer Center
            address:
               name:Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
               type:PostalAddress
            type:Organization
      name:James N. Kochenderfer
      affiliation:
            name:Experimental Transplantation and Immunology Branch, National Cancer Institute
            address:
               name:Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, USA
               type:PostalAddress
            type:Organization
      name:Sattva S. Neelapu
      affiliation:
            name:The University of Texas MD Anderson Cancer Center
            address:
               name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
               type:PostalAddress
            type:Organization
      name:Marcela V. Maus
      affiliation:
            name:Massachusetts General Hospital/Harvard Medical School
            address:
               name:Massachusetts General Hospital/Harvard Medical School, Boston, USA
               type:PostalAddress
            type:Organization
      name:David L. Porter
      affiliation:
            name:Perelman School of Medicine at the University of Pennsylvania
            address:
               name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:David G. Maloney
      affiliation:
            name:Fred Hutchinson Cancer Research Center
            address:
               name:Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA
               type:PostalAddress
            type:Organization
      name:Stephan A. Grupp
      affiliation:
            name:Perelman School of Medicine at the University of Pennsylvania
            address:
               name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
               type:PostalAddress
            type:Organization
            name:Cancer Immunotherapy Program, Children’s Hospital of Philadelphia
            address:
               name:Division of Oncology, Cancer Immunotherapy Program, Children’s Hospital of Philadelphia, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Crystal L. Mackall
      affiliation:
            name:Stanford University
            address:
               name:Cancer Immunology and Immunotherapy Program, Stanford University, Stanford, USA
               type:PostalAddress
            type:Organization
      name:Carl H. June
      affiliation:
            name:Perelman School of Medicine at the University of Pennsylvania
            address:
               name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
               type:PostalAddress
            type:Organization
      name:Michael R. Bishop
      url:http://orcid.org/0000-0001-6708-1536
      affiliation:
            name:University of Chicago
            address:
               name:Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
            name:The University of Chicago
            address:
               name:The University of Chicago, Chicago, USA
               type:PostalAddress
            type:Organization
      email:[email protected]
PostalAddress:
      name:University of Pittsburgh, Pittsburgh, USA
      name:Winship Cancer Institute, Emory University, Atlanta, USA
      name:Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA
      name:Experimental Transplantation and Immunology Branch, National Cancer Institute, Bethesda, USA
      name:Department of Lymphoma/Myeloma, The University of Texas MD Anderson Cancer Center, Houston, USA
      name:Massachusetts General Hospital/Harvard Medical School, Boston, USA
      name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
      name:Clinical Research Division, Fred Hutchinson Cancer Research Center, Seattle, USA
      name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
      name:Division of Oncology, Cancer Immunotherapy Program, Children’s Hospital of Philadelphia, Philadelphia, USA
      name:Cancer Immunology and Immunotherapy Program, Stanford University, Stanford, USA
      name:Perelman School of Medicine at the University of Pennsylvania, Philadelphia, USA
      name:Section of Hematology/Oncology, Department of Medicine, University of Chicago, Chicago, USA
      name:The University of Chicago, Chicago, USA

External Links {🔗}(285)

Analytics and Tracking {📊}

  • Google Tag Manager

Libraries {📚}

  • Clipboard.js
  • Prism.js

CDN Services {📦}

  • Crossref

4.83s.